These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8525684)

  • 21. New approaches for mucosal vaccines for AIDS: encapsidation and serial passages of poliovirus replicons that express HIV-1 proteins on infection.
    Morrow CD; Porter DC; Ansardi DC; Moldoveanu Z; Fultz PN
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S61-6. PubMed ID: 7865335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral immunization with a live coxsackievirus/HIV recombinant induces gag p24-specific T cell responses.
    Gu R; Shampang A; Nashar T; Patil M; Fuller DH; Ramsingh AI
    PLoS One; 2010 Sep; 5(9):. PubMed ID: 20824074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons.
    Choi WS; Pal-Ghosh R; Morrow CD
    J Virol; 1991 Jun; 65(6):2875-83. PubMed ID: 1851859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adenovirus vectored vaccines.
    Natuk RJ; Davis AR; Chanda PK; Lubeck MD; Chengalvala M; Murthy SC; Wade MS; Dheer SK; Bhat BM; Murthy KK
    Dev Biol Stand; 1994; 82():71-7. PubMed ID: 7958485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration.
    Lubeck MD; Natuk RJ; Chengalvala M; Chanda PK; Murthy KK; Murthy S; Mizutani S; Lee SG; Wade MS; Bhat BM
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1443-9. PubMed ID: 7888199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune responses against a new HIV-1 p24-gp41/pCAGGS-IL-12 DNA vaccine in Balb/c mice.
    Roodbari F; Sabahi F; Sarbolouki MN; Barkhordari F; Adeli A; Jamedar A; Mahboudi F
    Iran J Immunol; 2012 Jun; 9(2):86-97. PubMed ID: 22735796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of oral CTL vaccine using a CTP-integrated Sabin 1 poliovirus-based vector system.
    Han SS; Lee J; Jung Y; Kang MH; Hong JH; Cha MS; Park YJ; Lee E; Yoon CH; Bae YS
    Vaccine; 2015 Sep; 33(38):4827-36. PubMed ID: 26241946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eliciting HIV-1 envelope-specific antibodies with mixed vaccinia virus recombinants.
    Rencher SD; Lockey TD; Srinivas RV; Owens RJ; Hurwitz JL
    Vaccine; 1997 Feb; 15(3):265-72. PubMed ID: 9139484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional human immunodeficiency virus type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and env expressed from a single rhabdovirus-based vaccine vector genome.
    McGettigan JP; Naper K; Orenstein J; Koser M; McKenna PM; Schnell MJ
    J Virol; 2003 Oct; 77(20):10889-99. PubMed ID: 14512539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A poliovirus minireplicon containing an inactive 2A proteinase is expressed in vaccinia virus-infected cells.
    Pal-Ghosh R; Morrow CD
    J Virol; 1993 Aug; 67(8):4621-9. PubMed ID: 8392603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of virus-like Semliki Forest virus replicon particles expressing Indian HIV-1C gag, env and polRT genes.
    Ajbani SP; Velhal SM; Kadam RB; Patel VV; Lundstrom K; Bandivdekar AH
    Immunol Lett; 2017 Oct; 190():221-232. PubMed ID: 28851629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of mucosal HIV-specific B and T cell responses after oral immunization with live coxsackievirus B4 recombinants.
    Gu R; Stagnar C; Zaichenko L; Ramsingh AI
    Vaccine; 2012 May; 30(24):3666-74. PubMed ID: 22464964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Encapsidation studies of poliovirus subgenomic replicons.
    Barclay W; Li Q; Hutchinson G; Moon D; Richardson A; Percy N; Almond JW; Evans DJ
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1725-34. PubMed ID: 9680136
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression in the muscle and central nervous system following intramuscular inoculation of encapsidated or naked poliovirus replicons.
    Jackson CA; Messinger J; Palmer MT; Peduzzi JD; Morrow CD
    Virology; 2003 Sep; 314(1):45-61. PubMed ID: 14517059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of humoral, mucosal, and cellular immune responses following co-immunization of HIV-1 Gag and Env proteins expressed by Newcastle disease virus.
    Khattar SK; Palaniyandi S; Samal S; LaBranche CC; Montefiori DC; Zhu X; Samal SK
    Hum Vaccin Immunother; 2015; 11(2):504-15. PubMed ID: 25695657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions.
    Ansardi DC; Morrow CD
    J Virol; 1995 Mar; 69(3):1540-7. PubMed ID: 7853487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
    Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
    J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.
    Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M
    J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.